메뉴 건너뛰기




Volumn 36, Issue 3, 2002, Pages 687-691

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; LONG ACTING DRUG; OCTREOTIDE; PLACEBO; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

EID: 0036725135     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35071     Document Type: Article
Times cited : (197)

References (22)
  • 5
    • 0029001687 scopus 로고
    • A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
    • (1995) N Engl J Med , vol.332 , pp. 1256-1261
  • 11
    • 0031958654 scopus 로고    scopus 로고
    • Octreotide in hepatocellular carcinoma
    • (1998) Gut , vol.42 , pp. 316-318
    • Shouval, D.1
  • 22
    • 0031782818 scopus 로고    scopus 로고
    • A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
    • (1998) Hepatology , vol.28 , pp. 751-755


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.